Question

Difficulty: EasyDiagnostic Workup and Test Sequencing

A 45-year-old man presents to the clinic complaining of increasing ring and shoe size over the past three years. He also reports excessive sweating, worsening snoring, and joint pain. Physical examination reveals coarse facial features, a prominent jaw, and enlarged, doughy hands. The physician strongly suspects a condition caused by a hyperfunctioning anterior pituitary adenoma. What is the correct sequence of the following diagnostic steps to evaluate this patient's condition? Arrange the items from the initial screening test to the final localization study.

  1. 1Measurement of serum insulin-like growth factor 1 (IGF-1) level
  2. 2Growth hormone measurement following an oral glucose tolerance test
  3. 3Magnetic resonance imaging (MRI) of the pituitary gland

Answer

The correct diagnostic sequence for suspected acromegaly is initial screening with serum IGF-1, followed by biochemical confirmation using an oral glucose tolerance test with growth hormone measurement, and finally anatomical localization using a pituitary MRI.
The diagnostic workup for acromegaly must strictly follow a sequence of screening, confirmation, and then localization. Insulin-like growth factor 1 (IGF-1) is the best initial screening test due to its steady plasma concentration. If elevated, the diagnosis is confirmed by demonstrating a lack of growth hormone suppression during an oral glucose tolerance test. Only after biochemical confirmation should a pituitary MRI be ordered to localize the adenoma, preventing the misattribution of symptoms to a benign, nonfunctioning incidentaloma.

Step-by-Step Solution

1
Assess the clinical presentation to determine the suspected condition.
The patient has classic signs of acromegaly, prompting a workup for excess growth hormone.
Identifying the likely syndrome dictates the specific hormonal testing algorithm.
2
Select the initial screening test.
Serum IGF-1 level is chosen as the first step.
Because growth hormone is secreted in a pulsatile manner and fluctuates widely, a random growth hormone level is unhelpful. IGF-1 provides a stable, integrated assessment of growth hormone secretion.
3
Determine the confirmatory diagnostic test.
An oral glucose tolerance test (OGTT) with growth hormone measurement is chosen next.
A high IGF-1 must be confirmed by dynamic testing. In a healthy individual, a glucose load suppresses growth hormone. Failure to suppress confirms autonomous secretion.
4
Choose the appropriate imaging modality for localization.
An MRI of the pituitary gland is the final step.
Imaging is only indicated after biochemical confirmation to localize the source of excess growth hormone and plan for surgical resection.

Key Concept

Diagnostic sequencing for acromegaly always begins with biochemical testing (IGF-1 screening followed by OGTT confirmation) prior to anatomical imaging (pituitary MRI).
Rate this question